Today we announced that five abstracts on our investigational mRNA therapeutics for rare diseases have been accepted for presentation at the 2025 International Congress of Inborn Errors of Metabolism (ICIEM), which will be held September 2-6, 2025, in Kyoto, Japan. Read more: https://t.co/iHMaDO5ylt